HeimBHC • TSE
add
Bausch Health Companies Inc
Við síðustu lokun
6,82 $
Dagbil
6,48 $ - 6,95 $
Árabil
5,45 $ - 13,74 $
Markaðsvirði
2,41 ma. CAD
Meðalmagn
442,53 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 2,26 ma. | 4,92% |
Rekstrarkostnaður | 1,29 ma. | 6,18% |
Nettótekjur | -58,00 m. | 9,38% |
Hagnaðarhlutfall | -2,57 | 13,47% |
Hagnaður á hvern hlut | 0,61 | 2,86% |
EBITDA | 574,00 m. | -7,27% |
Virkt skatthlutfall | -82,98% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,13 ma. | 54,71% |
Heildareignir | 26,42 ma. | -1,83% |
Heildarskuldir | 26,66 ma. | -1,57% |
Eigið fé alls | -240,00 m. | — |
Útistandandi hlutabréf | 369,55 m. | — |
Eiginfjárgengi | -2,13 | — |
Arðsemi eigna | 2,54% | — |
Ávöxtun eigin fjár | 3,14% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -58,00 m. | 9,38% |
Handbært fé frá rekstri | 211,00 m. | 0,00% |
Reiðufé frá fjárfestingum | -130,00 m. | -78,08% |
Reiðufé frá fjármögnun | -146,00 m. | 57,06% |
Breyting á handbæru fé | -44,00 m. | 78,74% |
Frjálst peningaflæði | 149,88 m. | -51,81% |
Um
Bausch Health Companies Inc. is a global, diversified American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in eye health, gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufacture and market branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.
On 13 July 2018, as Quebec, Canada-based Valeant Pharmaceuticals International, it changed its name to Bausch Health Companies. Wikipedia
Framkvæmdastjóri
Stofnsett
1959
Höfuðstöðvar
Vefsvæði
Starfsfólk
20.700
